In David Eisenberg's lab at UCLA, researchers focus on developing new treatments for Alzheimer’s Disease by studying the structures of toxic proteins in the brain. They utilize advanced imaging techniques to uncover the shapes of these protein aggregates, which contribute to dementia. The lab aims to design drugs that can disrupt and dissolve these harmful aggregates while testing their effectiveness in lab-grown mini-brains, offering a more relevant model for human brain health.

Dr. Katherine Narr's lab at UCLA focuses on improving the effectiveness of Electroconvulsive Therapy (ECT) for treating major depression. They are investigating how to enhance the benefits of ECT while minimizing cognitive side effects. By integrating various data types, including neuroimaging and clinical assessments, the lab aims to establish tailored approaches for ECT dosage to ensure better outcomes for patients.

Dr. Benjamin M. Ellingson's lab at UCLA focuses on understanding glioblastoma, an aggressive form of brain cancer, and developing better imaging methods to guide treatment. His team investigates how certain proteins and imaging techniques can predict patient response to therapies that block blood vessel growth. By combining advanced MRI imaging with clinical data, they aim to create reliable biomarkers that help tailor treatments, improving outcomes for patients battling this challenging disease.

Dr. Hsian-Rong Tseng's lab at UCLA focuses on developing innovative ways to monitor treatment responses in pediatric patients with osteosarcoma, a type of bone cancer. The lab is working on a noninvasive test that analyzes extracellular vesicles (tiny particles released by tumors) to assess the activity of specific enzymes involved in cancer progression. This research aims to improve current diagnostic methods, offering better ways to track how well treatments are working for young patients with this aggressive disease.

Dr. Yi Tang's lab at UCLA focuses on discovering and understanding natural products from fungi, which are small molecules with significant effects on health. The research highlights the biosynthesis processes these compounds undergo, particularly exploring unique enzymes that produce these natural products. Through innovative techniques, the lab seeks to unravel the chemical logic behind complex natural structures and find new compounds that can be beneficial for various health applications.

Dr. Paul T. Spellman's lab at UCLA focuses on understanding how genetic factors influence the development and aggressiveness of prostate cancer. The lab investigates the role of germline genomic variations in the evolution of prostate cancer, aiming to improve risk assessment and treatment strategies for this common and serious disease. By analyzing large patient cohorts and using advanced bioinformatics methods, they seek to uncover insights that can help predict the risk of aggressive prostate cancer in men.

Dr. Amy Goldberg's lab at UCLA focuses on understanding how malaria parasites, particularly those that come from primate populations, can infect humans and lead to outbreaks. By studying the genetics of these parasites, especially a type called P. simium from Brazil, the lab aims to uncover the changes that allow these parasites to jump from one species to another. This research is crucial for predicting and preventing new malaria cases and developing effective treatments.

Dr. Peyman Golshani's lab at UCLA focuses on understanding the neural mechanisms underlying social behavior and memory, especially in relation to autism and aging. The lab employs advanced imaging techniques to explore how specific brain circuits function and how they can be modified to improve social interactions and memory linking. By studying these processes in animal models, the lab aims to uncover potential therapeutic targets for social deficits in autism and cognitive decline in aging.

The MicroED Imaging Center (MEDIC) at UCLA focuses on advancing the Microcrystal Electron Diffraction (MicroED) technique, enabling researchers to determine new molecular structures at atomic resolution from tiny crystals. By combining cutting-edge instrumentation and established crystallography methods, the lab trains individuals and collaborates with various partners to optimize and disseminate this technology. MEDIC aims to support both academic research and broader biomedical applications.

Dr. Elaine Hsiao's lab at UCLA focuses on understanding how the gut microbiome affects the responses to antidepressant treatments, particularly during pregnancy. By studying the interactions between the gut microbiome and selective serotonin reuptake inhibitors (SSRIs), the lab aims to improve treatments for antenatal depression and reduce potential risks to both mothers and their babies. The research could lead to safer and more effective strategies for managing depression during pregnancy.

Dr. Yousang Gwack's lab at UCLA explores how genetic factors influence the immune system, particularly focusing on T cells and their response to autoimmune diseases. By examining mitochondrial function and integrity, the lab seeks to uncover the mechanisms that make some T cells more prone to attacking the body, which can lead to diseases such as arthritis and diabetes. Their work combines advanced genetic screening in mice with sophisticated imaging techniques to better understand these processes and push towards new treatments.

The Hill lab at UCLA studies a peculiar type of parasite known as Trypanosoma brucei, which causes a serious illness called sleeping sickness in humans and livestock. Their research focuses on understanding the structure and function of the parasite's flagellum, a tail-like structure crucial for its movement and interaction with its environment. The lab utilizes advanced microscopy techniques to explore how these parasites assemble their flagella and how this knowledge can lead to new ways of treating diseases caused by similar parasites.

Dr. Alexander Hoffmann's lab at UCLA focuses on understanding how macrophages, which are crucial immune cells, respond to different stimuli and pathogens. The lab studies the mechanisms behind macrophage immune training, which is when past exposures reshape their future responses. By analyzing how these cells undergo epigenomic changes and how different transcription factors like IRFs shape their behavior, the lab aims to uncover insights that could inform treatments for infectious and inflammatory diseases.

Dr. Nasim Annabi's lab focuses on developing innovative hydrogel materials to improve the delivery of mesenchymal stem cells for corneal regeneration. By engineering biomimetic adhesives that can encapsulate and release these cells effectively, the lab aims to enhance healing after corneal injuries and reduce inflammation. This research could lead to significant advancements in treating corneal diseases and improving the quality of life for patients.

Dr. Eleazar Eskin's lab at UCLA focuses on developing advanced sequencing technologies for rapid mass testing of infectious diseases, particularly emerging pathogens like COVID-19 and monkeypox. The lab utilizes next-generation sequencing to analyze multiple samples simultaneously, enabling efficient detection of viruses and their variants. Their work aims to enhance public health response capabilities by facilitating large-scale screening and diagnosis in response to outbreaks.

Dr. Alicia Izquierdo's lab at UCLA focuses on understanding how the brain learns and adapts in uncertain environments, particularly in individuals with Substance Use Disorder. By examining the interactions between the amygdala and different areas of the prefrontal cortex, the lab is working to uncover how these brain regions influence decision-making and behavioral adjustments. This research aims to develop new insights and methods for addressing issues related to learning and behavior in the context of addiction.

Dr. Neema Jamshidi's research lab at UCLA focuses on improving our understanding and treatment of pancreatic cancer, a highly aggressive type of cancer with poor survival rates. The lab integrates various diagnostic techniques, including imaging and molecular profiling, to identify distinct characteristics of the tumor environment. By combining data from multiple sources, they aim to create non-invasive imaging tests for better diagnosis and potential new treatment targets.

Dr. Kamariza's lab focuses on developing innovative diagnostic tools to tackle tuberculosis, particularly drug-resistant strains. By creating a new rapid drug susceptibility test, the lab aims to improve the identification of TB and its resistance to treatments, especially in low-resource settings. This research is crucial for enhancing global healthcare responses to tuberculosis, a leading infectious disease threat.

The lab directed by Dr. Song Li at UCLA focuses on cell engineering, particularly enhancing the process of reprogramming somatic cells into induced neuronal cells using mechanical factors. They explore how manipulating the physical properties of cell nuclei can affect gene expression and chromatin structure, paving the way for advancements in regenerative medicine, disease modeling, and drug discovery.

Dr. Tyler R Clites' lab focuses on innovating solutions for patients with limb pathologies through a combination of engineering and surgical design. The aim is to create compliant, implantable prostheses that can restore natural joint function and alleviate pain for those suffering from injuries or diseases affecting their limbs. The lab's interdisciplinary work seeks to revolutionize limb salvage options and ultimately improve the quality of life for affected individuals.